Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 289, Issue 1 52-1, 2005, Pages

  Rust, Christian ^a   Bauchmuller, Kris ^a   Fickert, Peter ^b   Fuchsbichler, Andrea ^b   Beuers, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bile acids; Bile secretion; Cell signaling; Cholestasis; Liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CYTOKERATIN 18; GLYCOCHENODEOXYCHOLIC ACID; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TAUROCHENODEOXYCHOLIC ACID; WORTMANNIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE FLOW; BILE SECRETION; CHOLESTASIS; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GAS CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL DAMAGE; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BILE; CHOLESTASIS; ENZYME ACTIVATION; GLYCOCHENODEOXYCHOLIC ACID; LIVER DISEASES; PERFUSION; PROTEIN KINASE INHIBITORS; RATS; SIGNAL TRANSDUCTION; TAUROCHENODEOXYCHOLIC ACID;

EID: 21744449745     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00450.2004     Document Type: Article

References (34)

1. Arcaro A, Khanzada UK, Vanhaesebroeck B, Tetley TD, Waterfield MD, and Seckl MJ. Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J 21: 5097-5108, 2002.
2. Bergmeyer H and Bernt E. In: Methods of Enzymatic Analysis, edited by Bergmeyer H. Orlando, FL: Academic, 1983, p. 574-579.
3. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, and Dombrowski F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33: 1206-1216, 2001.
4. Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, and Boyer JL. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem 278: 17810-17818, 2003.
5. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
6. Datta SR, Brunet A, and Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
7. Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, and Moscat J. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86: 777-786, 1996.
8. Faubion W, Guicciardi M, Miyoshi H, Bronk S, Roberts P, Svingen P, Kaufmann S, and Gores G. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103: 137-145, 1999.
9. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, and Trauner M. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123: 1238-1251, 2002.
10. Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, and Shepherd PR. Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem 277: 37124-37130, 2002.
11. Franke T, Kaplan D, and Cantley L. PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437, 1997.
12. Fukumoto Y, Murakami F, Tateishi A, Itoh Y, Sakaida I, and Okita K. Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat. Hepatol Res 11: 214-222, 2002.
13. Higuchi H, Grambihler A, Canbay A, Bronk SF, and Gores GJ. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279: 51-60, 2004.
14. Hofmann AF. Chemistry and enterohepatic circulation of bile acids. Hepatology 4: 4S-14S, 1984.
15. Hofmann AF. Cholestatic liver disease: pathophysiology and therapeutic options. Liver 11, Suppl 2: 14-19, 2002.
16. Javitt J. Cholestasis in rats induced by taurolithocholate. Nature 210: 1262-1263, 1966.
17. Kitani K, Kanai S, Sato Y, and Ohta M. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. Hepatology 19: 1007-1012, 1994.
18. McConkey M, Gillin H, Webster CR, and Anwer MS. Cross-talk between protein kinases C-zeta and B in cyclic AMP-mediated sodium taurocholate co-transporting polypeptide translocation in hepatocytes. J Biol Chem 279: 20882-20888, 2004.
19. Misra S, Ujházy P, Gatmaitan Z, Varticovski L, and Arias I. The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver. J Biol Chem 273: 26638-26644, 1998.
20. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, and Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117: 669-677, 1999.
21. Reinehr R, Graf D, and Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125: 839-853, 2003.
22. Rodrigues CM, Fan G, Ma X, Kren BT, and Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101: 2790-2799, 1998.
23. Rodrigues CM and Steer CJ. Bile acids and hepatocyte apoptosis: living/leaving life in the Fas lane. Gastroenterology 117: 732-736, 1999.
24. Rust C, Karnitz LM, Paya CV, Moscat J, Simari RD, and Gores GJ. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275: 20210-20216, 2000.
25. Schmucker DL, Ohta M, Kanai S, Sato Y, and Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12: 1216-1221, 1990.
26. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, and Moshage H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563-1573, 2004.
27. +-induced apoptosis of cerebellar granule neurons via Akt kinase activation. FEBS Lett 437: 221-224, 1998.
28. 13C-labeled bile acids. J Lipid Res 25: 1313-1319, 1984.
29. Takikawa Y, Miyoshi H, Rust C, Roberts P, Siegel R, Mandal PK, Millikan RE, and Gores GJ. The bile acid-activated phosphatidylinositol 3-kinase pathway inhibits fas apoptosis upstream of bid in rodent hepatocytes. Gastroenterology 120: 1810-1817, 2001.
30. Ui M, Okada T, Hazeki K, and Hazeki O. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 20: 303-307, 1995.
31. Vanhaesebroeck B and Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253: 239-254, 1999.
32. Wahllander A and Sies H. Glutathione S-conjugate formation from 1-chloro-2,4-dinitrobenzene and biliary S-conjugate excretion in the perfused rat liver. Eur J Biochem 96: 441-446, 1979.
33. Webster CR and Anwer MS. Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver Ntcp. Am J Physiol Gastrointest Liver Physiol 277: G1165-G1172, 1999.
34. Yoon JH and Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol 37: 400-410, 2002.